Lataa...
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Copper-64 (T(1/2) = 12.7 hours; β(+), 0.653 MeV [17.8 %]; β(−), 0.579 MeV [38.4 %]) has decay characteristics that allow for positron emission tomography (PET) imaging and targeted radiotherapy of cancer. The well-established coordination chemistry of copper allows for its reaction with a wide varie...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc.
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2794299/ https://ncbi.nlm.nih.gov/pubmed/19694573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2009.0674 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|